124 related articles for article (PubMed ID: 32335556)
1. Management and Prognosis of Localized Duodenal Neuroendocrine Neoplasms.
Gay-Chevallier S; de Mestier L; Perinel J; Forestier J; Hervieu V; Ruszniewski P; Millot I; Valette PJ; Pioche M; Lombard-Bohas C; Subtil F; Adham M; Walter T
Neuroendocrinology; 2021; 111(8):718-727. PubMed ID: 32335556
[TBL] [Abstract][Full Text] [Related]
2. Surgical resection for duodenal neuroendocrine neoplasia: Outcome, prognostic factors and risk of metastases.
Nießen A; Bergmann F; Hinz U; Schimmack S; Hackert T; Büchler MW; Strobel O
Eur J Surg Oncol; 2020 Jun; 46(6):1088-1096. PubMed ID: 32088004
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience.
Massironi S; Campana D; Partelli S; Panzuto F; Rossi RE; Faggiano A; Brighi N; Falconi M; Rinzivillo M; Delle Fave G; Colao AM; Conte D
Ann Surg Oncol; 2018 Oct; 25(11):3200-3206. PubMed ID: 30054824
[TBL] [Abstract][Full Text] [Related]
4. Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy.
Rossi RE; Milanetto AC; Andreasi V; Campana D; Coppa J; Nappo G; Rinzivillo M; Invernizzi P; Modica R; David A; Partelli S; Lamberti G; Mazzaferro V; Zerbi A; Panzuto F; Pasquali C; Falconi M; Massironi S;
J Endocrinol Invest; 2021 Oct; 44(10):2227-2234. PubMed ID: 33651317
[TBL] [Abstract][Full Text] [Related]
5. A "Watch and Wait" Strategy Involving Regular Endoscopic Surveillance Is Safe for Many Patients with Small, Sporadic, Grade 1, Non-Ampullary, Non-Functioning Duodenal Neuroendocrine Tumours.
Exarchou K; Moore AR; Smart HL; Duckworth CA; Howes N; Pritchard DM
Neuroendocrinology; 2021; 111(8):764-774. PubMed ID: 32937631
[TBL] [Abstract][Full Text] [Related]
6. A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis.
Margonis GA; Samaha M; Kim Y; Postlewait LM; Kunz P; Maithel S; Tran T; Berger N; Gamblin TC; Mullen MG; Bauer TW; Pawlik TM
J Gastrointest Surg; 2016 Jun; 20(6):1098-105. PubMed ID: 27008594
[TBL] [Abstract][Full Text] [Related]
7. Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?
Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Kooby DA; Winer JH; Shah MM; Russell MC; Cardona K; Maithel SK
J Surg Oncol; 2019 Dec; 120(8):1293-1301. PubMed ID: 31621090
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.
Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):528-534. PubMed ID: 29164413
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Endoscopic Mucosal Resection for Management of Small Duodenal Neuroendocrine Tumors.
Shroff SR; Kushnir VM; Wani SB; Gupta N; Jonnalagadda SS; Murad F; Early DS; Mullady DK; Edmundowicz SA; Azar RR
Surg Laparosc Endosc Percutan Tech; 2015 Oct; 25(5):e134-9. PubMed ID: 26271024
[TBL] [Abstract][Full Text] [Related]
10. [Non-functional duodenal neuroendocrine neoplasia in the proximal duodenum--case reports and proposal for a "high-risk-/low-risk-concept" in the decision for local endoscopic therapy].
Scheerer F; Schmitt W
Z Gastroenterol; 2013 Nov; 51(11):1240-50. PubMed ID: 24243571
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic features and management options for duodenal neuroendocrine neoplasms: a retrospective, multi-centre study.
Mandair D; Kamieniarz L; Pizanias M; Weickert MO; Narayan A; O'Mahony LF; Caplin M; Ramage J; Prachalias A; Srirajaskanthan R; Toumpanakis C
Sci Rep; 2022 Sep; 12(1):15762. PubMed ID: 36130981
[TBL] [Abstract][Full Text] [Related]
12. Duodenal neuroendocrine neoplasms with unexpectedly aggressive behaviour: Challenging the "watch and wait" approach.
Ratnayake GM; Srirajaskanthan R; Luong T; Gnanasegaran G; Toumpanakis C
J Neuroendocrinol; 2022 Jan; 34(1):e13067. PubMed ID: 34914146
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
[No Abstract] [Full Text] [Related]
14. Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence?
Massironi S; Rossi RE; Milanetto AC; Andreasi V; Campana D; Nappo G; Partelli S; Gallo C; Scaravaglio M; Zerbi A; Panzuto F; Pasquali C; Falconi M; Invernizzi P; On Behalf Of ItaNet Italian Association For Neuroendocrine Tumours Study Group
J Clin Med; 2022 May; 11(9):. PubMed ID: 35566783
[TBL] [Abstract][Full Text] [Related]
15. Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management.
Weatherall T; Denbo J; Sharpe J; Martin M; O'Brien T; Gupta R; Groshart K; Behrman S; Dickson P
World J Surg; 2017 Mar; 41(3):844-850. PubMed ID: 27743074
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
17. Treatment Results of Endoscopic Mucosal Resection with a Ligation Device for Duodenal Neuroendocrine Tumors.
Fujimoto A; Sasaki M; Goto O; Maehata T; Ochiai Y; Kato M; Nakayama A; Akimoto T; Kuramoto J; Hayashi Y; Kameyama K; Yahagi N
Intern Med; 2019 Mar; 58(6):773-777. PubMed ID: 30449790
[TBL] [Abstract][Full Text] [Related]
18. Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity.
Rossi RE; Rausa E; Cavalcoli F; Conte D; Massironi S
Scand J Gastroenterol; 2018; 53(7):835-842. PubMed ID: 29726295
[TBL] [Abstract][Full Text] [Related]
19. Favorable long-term outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumor.
Matsueda K; Kanesaka T; Kitamura M; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Honma K; Miyashiro I; Ishihara R
J Gastroenterol Hepatol; 2021 Dec; 36(12):3329-3336. PubMed ID: 34142385
[TBL] [Abstract][Full Text] [Related]
20. A novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms.
Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
Oncotarget; 2016 Jul; 7(27):42045-42058. PubMed ID: 27275541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
